EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancer: testing combo therapy when first treatments fail
Disease control Not yet recruitingThis study is testing a new two-drug combination for people with extensive-stage small cell lung cancer whose cancer has gotten worse after their first treatment. The treatment combines an intravenous drug that targets cancer cells with a daily pill that aims to cut off the tumor…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Double attack on deadly cancer: new trial aims to control aggressive tumors
Disease control Not yet recruitingThis study is testing whether combining two newer cancer drugs can help control aggressive small cell lung cancer and similar neuroendocrine cancers that have returned or stopped responding to standard treatments. The trial will enroll about 120 adults whose cancer has progressed…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for aggressive lung cancer: major trial launches
Disease control Not yet recruitingThis large Phase 3 trial will compare a new experimental drug, BL-B01D1, combined with an immunotherapy (tislelizumab) against the current standard platinum-based chemotherapy combined with the same immunotherapy. It aims to see if the new combination helps people with extensive-…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New combo therapy aims to keep aggressive lung cancer at bay
Disease control Not yet recruitingThis study is testing whether a combination of two drugs, lurbinectedin and durvalumab, can help control extensive-stage small cell lung cancer after initial chemotherapy. It is for patients whose cancer has not gotten worse after their first round of treatment. The main goal is …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Doctors track lung cancer patients to unlock better treatment secrets
Knowledge-focused Not yet recruitingThis study aims to understand how patients with advanced small cell lung cancer respond to standard treatments in everyday hospital practice. Researchers will observe 96 patients receiving their normal care, collecting health data over time to see which approaches work best. The …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC